Tag Archives: Cipher

Buy Cipher Pharma Before Someone Else Buys Them

By Jason Napodano: We believe Cipher Pharmaceuticals (OTC:CPHMF) (DND.TO) is a very attractive acquisition target by a larger pharmaceutical organization. Below we provide a quick review of the solid fundamentals that led to break-out financial results in 2013, and conclude … Continue reading

Posted in Finance | Tagged , , , , , , | Leave a comment

Cipher Banking On Absorica, Literally

By Jason Napodano: By Jason Napodano, CFA This morning, Cipher Pharmaceuticals (DND.TO) (CPHMF.PK) posted an updated investor presentation on its website. It shows that business is chugging along nicely at Cipher. Back in May 2013, we announced that we were … Continue reading

Posted in Finance | Tagged , , , | Leave a comment

Cipher Pharma Continues To Deliver

By Jason Napodano: On May 3, 2013, Cipher Pharmaceuticals (CPHMF.PK) reported financial results for the first quarter 2013. Total revenue in the quarter was $ 3.3 million, up 82% over the first quarter 2012 and nicely ahead of our estimate … Continue reading

Posted in Finance | Tagged , , , | Leave a comment

Transformation Underway At Cipher

By Jason Napodano: By Jason Napodano, CFA On May 27, 2012, Cipher Pharmaceuticals (DND.TO) (CPHMF.PK) announced it had received U.S. FDA approval of Absorica, the company’s novel, patented brand formulation of the acne medication isotretinoin, for the treatment of severe … Continue reading

Posted in Finance | Tagged , , | Leave a comment